-
World Liquid Biopsy Markets Report 2021: Liquid Biopsy Progress Delayed by COVID Pandemic but Huge Cancer Screening Opportunity Still Looms - Forecast to 2025
prnewswire
October 13, 2021
The "Liquid Biopsy Markets by Cancer Type and by Usage Type with Impact of COVID-19 Pandemic. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2021-2025" report...
-
AstraZeneca and Oncoshot establish strategic partnership to better streamline recruitment process for cancer clinical trials
prnasia
September 28, 2021
Singapore's cancer population may benefit from improved access to cutting-edge clinical trials through InSite Feasibility - Oncoshot's new digital platform that facilitates...
-
Blood test can detect more than 50 types of cancer
pharmatimes
June 28, 2021
Researchers have developed a blood test able detect more than 50 types of cancer that is accurate enough to be used nationally as a multi-cancer screening test in those at higher risk of the disease, including those aged over 50 with no symptoms.
-
ARPA-H: Biden’s proposed government health agency hopes to cure cancer
pharmaceutical-technology
June 09, 2021
The White House has requested $6.5bn of federal funding for an agency to investigate treatments for cancer and other diseases.
-
Lupin announces achievement of key milestones for its clinical stage MEK inhibitor compound
expresspharma
May 31, 2021
Lupin’s MEK inhibitor compound is planned for clinical development in combination with Boehringer Ingelheim’s KRAS inhibitor pipeline to address KRAS-driven cancers.
-
Beroni, tella Sign MoU for Cancer Immunotherapy Treatment
contractpharma
May 31, 2021
Beroni Group, an Australia-based biopharmaceutical enterprise, has signed a Memorandum of Understanding with tella, Inc. to collaborate in the field of immunotherapy for cancer treatment.
-
NHS England funds first national metastatic breast cancer audit
pharmatimes
May 25, 2021
NHS England (NHSE) has announced that it will fund the first ever national metastatic breast cancer audit, in a bid to provide accurate figures of how many people in England are living with secondary breast cancer.
-
As Medicaid Access Expands, So Does Cancer Survival
drugs
May 20, 2021
More lower-income Americans are surviving cancer due to expanded Medicaid health care coverage, a new study shows.
-
Farrer Park Hospital Elevates Cancer Care with PIPAC Treatment for Late to End-stage Cancer Patients
prnasia
May 19, 2021
Farrer Park Hospital has introduced the pressurized intraperitoneal aerosolized chemotherapy (PIPAC) treatment for patients with peritoneal cancer, offering this vulnerable group a second chance to achieve better quality of life.
-
DarwinHealth Announces a Research Collaboration with Bristol Myers Squibb for a Novel Cancer Target Discovery (NCTI) Initiative
prnasia
May 07, 2021
DarwinHealth, a New York City-based biotechnology company, announced a scientific research collaboration with Bristol-Myers Squibb Company.